MDS Virtual Congress 2021

September 17-22, 2021. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Indirect Treatment Comparison of Adjunctive Treatments for Patients with Parkinson’s Disease Experiencing Motor Complications

D. Kremens, W. Oertel, R. Pahwa, R. Hauser, C. Lecureuil, R. Johnson, G. Went (Philadelphia, USA)
Induction of Parkinsonian-like changes via targeted down-regulation of astrocytic glutamate transporter GLT-1 in the striatum

C. Ren, K-J. He, J-B. Zhang, L-G. Dong, F. Wang, C-F. Liu (Suzhou, China)
Influence of deep brain stimulation on premotor-motor interaction in patients with Parkinson’s disease

M. Pauly, M. Barlage, F. Hamami, J. Steinhardt, J. Baarbe, S. Tran, H. Hanssen, V. Tadic, N. Brueggemann, R. Chen, A. Muenchau, T. Baeumer, A. Weissbach (Luebeck, Germany)
Influence of demographic characteristics on the effectiveness of opicapone in Parkinson’s disease patients with motor fluctuations: findings from the real-world OPTIPARK study

B. Mohamed, A. Lees, H. Reichmann, D. Martins, D. Magalhães, J. Rocha, P. Soares-da-Silva (Cardiff, United Kingdom)
Influence of Dopamine Transporter Gene Polymorphism on Wearing Off

CE. Mantese, V. Altmann, A. Schumacher-Schuh, M. Hutz, CRM. Rieder (Porto Alegre, Brazil)
Influence of Levodopa on Archimedes Spiral Drawings in Idiopathic Parkinson’s Disease

L. Pillai, A. Glover, T. Virmani (Little Rock, USA)
Influence of onset of motor fluctuations on the effectiveness of opicapone in Parkinson’s disease patients with motor fluctuations: findings from the real-world OPTIPARK study

W. Jost, H. Reichmann, A. Lees, D. Marinho, D. Magalhães, J. Rocha, P. Soares-da-Silva (Wolfach, Germany)
Informant vs. Self-ratings of Activities of Daily Living in Parkinson’s Disease patients

S. Becker, S. Nussbaum, K. Michaelis, K. Brockmann, I. Liepelt-Scarfone (Calgary, Canada)
Informing the design of disease modifying trials for Parkinson’s disease – A Delphi study

M. Zeissler, R. Windle, K. Raphael, G. Rafaloff, K. Mcfarthing, H. Matthews, C. Carroll (Plymouth, United Kingdom)
Inhibition of GluN2D-containing NMDA receptors alleviates the loss of dopaminergic neurons and behavioral deficits in 6-OHDA-induced model of Parkinson’s disease

JB. Zhang, C. Ren, KJ. He, F. Wang, CF. Liu (Suzhou, China)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z